There are 25 stocks on Oppenheimer's latest SMID-cap list, including 12 new entries that weren't on the second-or third-quarter editions. Those new stocks are below — sorted in alphabetical orde ...

Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025.

Telehealth company Hims & Hers said late Monday in an earnings update that it plans to launch a generic version of Novo ...

But it does not mean people without diabetes can't experience it. Prediabetics, people who eat carbohydrate-rich foods or those who wait too long between meals may even suffer low blood sugar levels.

The groundbreaking study ... Popular Diabetes and Weight-Loss Drug May Reduce Risk of Alzheimer's Disease Oct. 24, 2024 — Researchers have found that semaglutide may lower the risk of Alzheimer ...

Mumbai: A year-long study on managing type 2 diabetes (T2D ... reducing dependency on anti-diabetic medications, and enhancing overall metabolic health. This innovative approach, conducted ...

While manufacturing issues and supply chain bottlenecks are common culprits in most prescription drug shortages, ADHD and diabetes medications ... He argued that a high list price is more likely ...

It will also allow the government to sign deals with provinces and territories to cover diabetes and birth-control medications as part of the public health system. The wording and content of the ...

The hemoglobin A1C test is a useful tool to help monitor glucose control or diagnose diabetes ... ordering your A1C test has an accurate list of your medications and any supplements you take.

It has been a long time coming: The active ingredient in the weight-loss drug Zepbound and diabetes medication Mounjaro ... from FDA’s drug-shortage list,” says FDA press officer Amanda ...